ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
0,00%
Dow Jones
38 589,16
-0,15%
DAX
18 020,49
0,00%
Brent Oil
81,775
-0,43%
Bitcoin
66 068,20
-0,86%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ironwood Pharmaceuticals Inc (IRWD)

  7. Ironwood Pharmaceuticals Inc (IRWD) Actualités

IRWD

Ironwood Pharmaceuticals (IRWD)

Ironwood Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IRWD
DateHeureSourceTitreSymboleSociété
12/06/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
10/06/202422h57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
30/05/202422h01Business WireIronwood Pharmaceuticals to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
21/05/202412h00Business WireIronwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)NASDAQ:IRWDIronwood Pharmaceuticals Inc
09/05/202422h46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
09/05/202413h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/05/202413h00Business WireIronwood Pharmaceuticals Reports First Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
06/05/202422h01Business WireIronwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
01/05/202413h30Business WireIronwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024NASDAQ:IRWDIronwood Pharmaceuticals Inc
25/04/202422h01Business WireIronwood Pharmaceuticals to Host First Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
28/03/202412h30Business WireIronwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)NASDAQ:IRWDIronwood Pharmaceuticals Inc
29/02/202412h00Business WireIronwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)NASDAQ:IRWDIronwood Pharmaceuticals Inc
23/02/202413h30Business WireIronwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
15/02/202413h00Business WireIronwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial GuidanceNASDAQ:IRWDIronwood Pharmaceuticals Inc
01/02/202422h01Business WireIronwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/01/202401h00Business WireIronwood Announces Publication in The Lancet Gastroenterology & Hepatology of New Linaclotide Phase III Data in Children and Adolescents Aged 6-17 Years with Functional ConstipationNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/01/202412h00Business WireIronwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial GuidanceNASDAQ:IRWDIronwood Pharmaceuticals Inc
03/01/202422h01Business WireIronwood Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
12/12/202322h01Business WireIronwood Announces the Completion of Squeeze-Out Merger With VectivBioNASDAQ:IRWDIronwood Pharmaceuticals Inc
21/11/202322h01Business WireIronwood Pharmaceuticals to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/11/202322h08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/11/202322h07Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:IRWDIronwood Pharmaceuticals Inc
09/11/202313h00Business WireIronwood Pharmaceuticals Reports Third Quarter 2023 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
26/10/202322h01Business WireIronwood Pharmaceuticals to Host Third Quarter 2023 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
23/10/202313h30Business WireIronwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific MeetingNASDAQ:IRWDIronwood Pharmaceuticals Inc
16/10/202312h00Business WireIronwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition, a Phase II Study of Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon in Continuity (CIC) at United European Gastroenterology WeekNASDAQ:IRWDIronwood Pharmaceuticals Inc
05/10/202313h30Business WireIronwood to Present New Data at NASPGHAN Annual Meeting Reinforcing Impact of Linaclotide on Functional Constipation in Children and Adolescents Ages 6-17 Years-OldNASDAQ:IRWDIronwood Pharmaceuticals Inc
11/09/202322h30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/202313h00Business WireIronwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue GuidanceNASDAQ:IRWDIronwood Pharmaceuticals Inc
25/07/202322h01Business WireIronwood Pharmaceuticals to Host Second Quarter 2023 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:IRWD

Dernières Valeurs Consultées

EU
CAP
Capgemini
EU
AI
Air Liquide
EU
ML
Michelin
EU
PX1
CAC 40
EU
RNO
Renault
NYSE
NKE
Nike
NASDAQ
AAPL
Apple
EU
BN
Danone
NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
EU
VIV
Vivendi
EU
LR
Legrand
USI
USTECH100
US Tech 100
EU
CS
Axa
EU
BEL20
Bel 20
EU
VK
Vallourec
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés